v3.26.1
Stockholders' Equity - Additional Information (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Aug. 31, 2026
Apr. 30, 2026
Mar. 31, 2026
Aug. 31, 2025
Feb. 29, 2024
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Class Of Stock [Line Items]                  
Aggregate common stock value sold           $ 89,752,000      
Issuance of common stock allocated to stock purchase option           3,688,000      
Net proceeds from issuance of common stock               $ 89,646,000 $ 254,000
Common Stock                  
Class Of Stock [Line Items]                  
Aggregate common stock value sold           $ 3,000      
Aggregate common stock sold           29,115,000      
Additional Paid-in Capital                  
Class Of Stock [Line Items]                  
Aggregate common stock value sold           $ 89,749,000      
Issuance of common stock allocated to stock purchase option           $ 3,688,000      
At The Market Offering                  
Class Of Stock [Line Items]                  
Aggregate common stock value sold             $ 315,000    
At The Market Offering | Common Stock                  
Class Of Stock [Line Items]                  
Aggregate common stock sold             170,000    
At The Market Offering | Additional Paid-in Capital                  
Class Of Stock [Line Items]                  
Aggregate common stock value sold             $ 315,000    
Over Allotment Option                  
Class Of Stock [Line Items]                  
Number of warrants to purchase common stock       1,500,000 12,700,000        
Net proceeds from issuance of common stock       $ 80,600,000 $ 180,000,000        
Underwritten Public Offering | Common Stock                  
Class Of Stock [Line Items]                  
Aggregate common stock sold       24,300,000 21,800,000        
Underwriters' Option To Purchase Additional Shares | Common Stock                  
Class Of Stock [Line Items]                  
Aggregate common stock sold       3,400,000 4,500,000        
February 2024 Underwritten Public Offering.                  
Class Of Stock [Line Items]                  
Pre-funded warrants exercised               2,200,000  
Description of pre-funded warrants exerciable               The pre-funded warrants are exercisable at any time; however, the holders of pre-funded warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to such exercise. The holders of pre-funded warrants may increase or decrease such percentages not in excess of 19.99% by providing at least 61 days’ prior notice to the Company.  
Maximum percentage of pre-funded warrants increase or decrease by providing atleast 61 days prior notice               19.99%  
Pre-funded warrants not exercise if holder together owns maximum percentage of number of common stock outstanding               4.99%  
August 2025 Underwritten Public Offering                  
Class Of Stock [Line Items]                  
Pre-funded warrants exercised           0   0  
Maximum percentage of pre-funded warrants increase or decrease by providing atleast 61 days prior notice               19.99%  
Pre-funded warrants not exercise if holder together owns maximum percentage of number of common stock outstanding               4.99%  
Mayo Clinic Initial Shares | Stock Purchase Agreement                  
Class Of Stock [Line Items]                  
Stock price price per share   $ 3.33              
Net proceeds from issuance of common stock   $ 25,000,000              
Mayo Clinic Initial Shares | Stock Purchase Agreement | Common Stock and Additional Paid-in Capital                  
Class Of Stock [Line Items]                  
Issuance of common stock allocated to stock purchase option               $ 21,300,000  
Mayo Clinic Election | Stock Purchase Agreement | Forecast                  
Class Of Stock [Line Items]                  
Stock price price per share $ 3.33                
Net proceeds from issuance of common stock $ 25,000,000                
Mayo Clinic Election | Stock Purchase Agreement | Additional Paid-in Capital                  
Class Of Stock [Line Items]                  
Issuance of common stock allocated to stock purchase option               $ 3,700,000  
Pre-Funded Warrants | February 2024 Underwritten Public Offering.                  
Class Of Stock [Line Items]                  
Exercise price of common stock per share           $ 0.0001   $ 0.0001  
Pre-Funded Warrants | August 2025 Underwritten Public Offering                  
Class Of Stock [Line Items]                  
Exercise price of common stock per share           $ 0.0001   $ 0.0001  
Cowen | At The Market Offering                  
Class Of Stock [Line Items]                  
Aggregate common stock sold           21,600,000      
Net proceeds from issuance of common stock           $ 68,600,000      
Cowen | At The Market Offering | Sales Agreement | Maximum                  
Class Of Stock [Line Items]                  
Aggregate common stock value sold     $ 150,000,000